VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+1.08%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$335M
AUM Growth
+$335M
(+62%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
38.38%
Top 10 Holdings %
Top 10 Hldgs %
47.51%
Holding
205
New
53
Increased
79
Reduced
42
Closed
30
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$24M |
| 2 |
iShares Short Treasury Bond ETF
SHV
|
$11.9M |
| 3 |
ETP
Energy Transfer Partners L.p.
ETP
|
$7.87M |
| 4 |
WPZ
Williams Partners L.P.
WPZ
|
$7.16M |
| 5 |
EEP
Enbridge Energy Partners
EEP
|
$5.92M |
Top Sells
| 1 |
Williams Companies
WMB
|
$1.75M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
$1.69M |
| 3 |
ProShares Ultra 20+ Year Treasury
UBT
|
$1.24M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$1.06M |
| 5 |
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
|
$1.02M |
Sector Composition
| 1 | Energy | 57.29% |
| 2 | Healthcare | 12.14% |
| 3 | Utilities | 3.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUMO
151
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $242K | 0.07% |
23,540
-923
| -4% | -$9.49K |
|
|
ONCE
152
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $242K | 0.07% |
4,847
-434
| -8% | -$21.7K |
|
153
Celldex Therapeutics
CLDX
$1.49B
| $241K | 0.07% |
68,024
+8,487
| +14% | +$30.1K |
|
|
AVXS
154
DELISTED
AveXis, Inc. Common Stock
AVXS
| $241K | 0.07% |
5,049
-820
| -14% | -$39.1K |
|
155
TG Therapeutics
TGTX
$4.66B
| $238K | 0.07% |
51,122
+15,825
| +45% | +$73.7K |
|
|
KITE
156
DELISTED
Kite Pharma, Inc.
KITE
| $238K | 0.07% |
5,313
+424
| +9% | +$19K |
|
157
Prothena Corp
PRTA
$449M
| $236K | 0.07% |
4,795
-714
| -13% | -$35.1K |
|
|
RDUS
158
DELISTED
Radius Health, Inc.
RDUS
| $233K | 0.07% |
6,130
-856
| -12% | -$32.5K |
|
|
AIMT
159
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $231K | 0.07% |
11,276
-8,225
| -42% | -$168K |
|
160
Lexicon Pharmaceuticals
LXRX
$400M
| $227K | 0.07% |
16,410
-1,239
| -7% | -$17.1K |
|
161
Neurocrine Biosciences
NBIX
$14.1B
| $227K | 0.07% |
5,854
+530
| +10% | +$20.6K |
|
|
GBT
162
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $227K | 0.07% |
15,719
+4,009
| +34% | +$57.9K |
|
|
BLUE
163
DELISTED
bluebird bio
BLUE
| $226K | 0.07% |
3,667
-2,498
| -41% | -$154K |
|
164
Puma Biotechnology
PBYI
$256M
| $226K | 0.07% |
7,366
-300
| -4% | -$9.2K |
|
165
PTC Therapeutics
PTCT
$4.18B
| $224K | 0.07% |
20,523
-14,326
| -41% | -$156K |
|
|
XLRN
166
DELISTED
Acceleron Pharma Inc.
XLRN
| $224K | 0.07% |
8,771
+1,861
| +27% | +$47.5K |
|
167
Minerva Neurosciences
NERV
$16.2M
| $221K | 0.07% |
18,814
-6,816
| -27% | -$80.1K |
|
168
Alnylam Pharmaceuticals
ALNY
$59.5B
| $219K | 0.07% |
5,857
+1,779
| +44% | +$66.5K |
|
169
Alaunos Therapeutics
TCRT
$4.49M
| $216K | 0.06% |
40,359
+184
| +0.5% | +$985 |
|
170
Amicus Therapeutics
FOLD
$2.38B
| $215K | 0.06% |
43,256
+2,551
| +6% | +$12.7K |
|
171
Agios Pharmaceuticals
AGIO
$2.25B
| $199K | 0.06% |
4,764
-304
| -6% | -$12.7K |
|
172
Vanguard Health Care ETF
VHT
$15.6B
| $186K | 0.06% |
+1,465
| New | +$186K |
|
|
173
Williams Companies
WMB
$69.4B
| $144K | 0.04% |
4,619
-56,101
| -92% | -$1.75M |
|
|
CEMP
174
DELISTED
Cempra, Inc.
CEMP
| $101K | 0.03% |
35,893
+22,609
| +170% | +$63.6K |
|
|
CNCE
175
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| – | – |
-20,939
| Closed | -$212K |
|